Shares in Delcath Systems (DCTH) nearly doubled Wednesday after the FDA announced that it had granted orphan status to melphalan for treatment of patients with hepatocellular carcinoma (primary
- 2 MIN READ
- 10.2.2013
© 2022 Equities News | Equities.com, Inc.